Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wang, Pei  [Clear All Filters]
2024
Wang P, Peng Z, Zhang Y, Zhang X, Chen X, Li F, Chen B, Niu S, Du K, Zhu L-M. A chitosan-camouflaged nanomedicine triggered by hierarchically stimuli to release drug for multimodal imaging-guided chemotherapy of breast cancer. Carbohydr Polym. 2024;335:122073.
2023
Guo Q, Zhao C, Gao X, Ding L, Wang P, Ren Y'nan, Hou X, Yao Y, Zhang C, Yang X, et al. One-Minute Iodine Isotope Labeling Technology Enables Noninvasive Tracking and Quantification of Extracellular Vesicles in Tumor Lesions and Intact Animals. Mol Pharm. 2023.
2022
Zeng W, Xiong L, Wu W, Li S, Liu J, Yang L, Lao L, Huang P, Zhang M, Chen H, et al. CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. Oncogene. 2022.
2021
Dou R, Zhang X, Xu X, Wang P, Yan B. Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization. Mol Immunol. 2021;139:106-114.
2015
Wang H, Luo X, Yao L, Lehman D, Wang P. Improvement of Cell Survival during Human Pluripotent Stem Cell Definitive Endoderm Differentiation. Stem Cells Dev. 2015.
2014
Sebastiano V, Zhen HHui, Derafshi BHaddad, Bashkirova E, Melo SP, Wang P, Leung TL, Siprashvili Z, Tichy A, Li J, et al. Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci Transl Med. 2014;6(264):264ra163.